Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
SubbaRao V. Madhunapantula, Paul J. Mosca & Gavin P. Robertson. (2011) The Akt signaling pathway. Cancer Biology & Therapy 12:12, pages 1032-1049.
Read now
Read now
Ettore Beghi, Caterina Bendotti & Tiziana Mennini. (2006) New ideas for therapy in ALS: Critical considerations. Amyotrophic Lateral Sclerosis 7:2, pages 126-127.
Read now
Read now
Articles from other publishers (3)
Yu Wen, Jiadong Li, Jasmine Koo, Seung-Shick Shin, Yong Lin, Byeong-Seon Jeong, Janice M. Mehnert, Suzie Chen, Karine A. Cohen-Sola & James S. Goydos. (2014) Activation of the Glutamate Receptor GRM1 Enhances Angiogenic Signaling to Drive Melanoma Progression. Cancer Research 74:9, pages 2499-2509.
Crossref
Crossref
Maithao N. Le, Joseph L.-K. Chan, Stephen A. Rosenberg, Adam S. Nabatian, Kim T. Merrigan, Karine A. Cohen-Solal & James S. Goydos. (2010) The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells. Journal of Investigative Dermatology 130:9, pages 2240-2249.
Crossref
Crossref
Dana Yip, Maithao N. Le, Joseph L.-K. Chan, Jonathan H. Lee, Janice A. Mehnert, Anthony Yudd, Jeffery Kempf, Weichung J. Shih, Suzie Chen & James S. Goydos. (2009) A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma. Clinical Cancer Research 15:11, pages 3896-3902.
Crossref
Crossref